These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

569 related items for PubMed ID: 4536903

  • 1. Analgesics and non-steroid anti-inflammatory agents in rheumatic disease.
    Hart FD.
    Practitioner; 1972 Jan; 208(243):10-7. PubMed ID: 4536903
    [No Abstract] [Full Text] [Related]

  • 2. Anti-inflammatory drugs in rheumatic diseases.
    Cosh JA.
    Practitioner; 1974 Oct; 213(1276 SPEC NO):519-26. PubMed ID: 4376236
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical trial of Midalgyl in rheumatology].
    Verhaeghe A, Delcambre B.
    Lille Med; 1971 Apr; 16():S 2:638-9. PubMed ID: 5317348
    [No Abstract] [Full Text] [Related]

  • 4. Which drugs for which rheumatic disorder?
    Br Med J; 1972 Apr 01; 2(5804):39-42. PubMed ID: 4536924
    [No Abstract] [Full Text] [Related]

  • 5. Inflammatory disease and its control in rheumatic disorders.
    Hart FD.
    Br Med J; 1975 Oct 25; 4(5990):191-4. PubMed ID: 1081416
    [No Abstract] [Full Text] [Related]

  • 6. Naproxen. Proceedings from an International Medical Symposium presented by Syntex Corporation 7-8 May 1973, Geneva, Switzerland.
    Scand J Rheumatol Suppl; 1973 Oct 25; 2():1-181. PubMed ID: 4544036
    [No Abstract] [Full Text] [Related]

  • 7. Selection of analgesics in the treatment of the rheumatic disorders.
    Hart FD.
    Proc R Soc Med; 1969 Jun 25; 62(6):539-40. PubMed ID: 5306583
    [No Abstract] [Full Text] [Related]

  • 8. [Therapeutic effects of non-steroid anti-inflammatory agents, with special reference to 2-4(4-isobutylphenyl)-propionic acid].
    Cremoncini C, Mola V.
    Minerva Med; 1973 Jun 20; 64(46):2423-35. PubMed ID: 4579327
    [No Abstract] [Full Text] [Related]

  • 9. Update: treatment of rheumatic disease.
    Solomon SD.
    J Med Soc N J; 1978 Nov 20; 75(12):855-8. PubMed ID: 361956
    [No Abstract] [Full Text] [Related]

  • 10. [Double-blind clinical study with placebo versus bumadizone-Ca in 113 patients with rheumatism].
    Medenica R, Abele I, Dobryk R, Kuzmanovic I, Junet R.
    Arzneimittelforschung; 1973 Dec 20; 23(12):1817-22. PubMed ID: 4544615
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Namoxyrate in rheumatic disorders.
    Denko CW, DeFelice EA, Shaffer J.
    Curr Ther Res Clin Exp; 1965 Dec 20; 7(12):749-58. PubMed ID: 4954445
    [No Abstract] [Full Text] [Related]

  • 18. [Medicamentous therapy of rheumatic diseases in the spa?].
    Pohl W.
    Munch Med Wochenschr; 1966 Sep 16; 108(37):1809-12. PubMed ID: 4296918
    [No Abstract] [Full Text] [Related]

  • 19. [On the use in anti-rheumatic therapy of a new non-steroid anti-inflammatory agent: glucosamide of monohydrated (N-p-chloro-benzoyl-2-methyl-5-methoxy)-indol-3-acetic acid].
    De Arcangelis A.
    Clin Ter; 1971 Nov 15; 59(3):229-39. PubMed ID: 5316735
    [No Abstract] [Full Text] [Related]

  • 20. Anti-inflammatory drugs in the treatment of rheumatic diseases.
    Hart FD.
    Practitioner; 1970 Nov 15; 205(229):597-603. PubMed ID: 5312818
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.